Application

18080242 · Sublingual Delivery for Mitigation of Side Effects Associated with Zicronapine

Filed 2022-12-13 · Abandoned The official file ↗ · Art unit 1611 · Examiner Isis A D Ghali Hard · CPC A61K 9/4808 · Vivera Pharmaceuticals Inc. · Vivera Pharmaceuticals Inc.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

30.0 mo

to disposition 37.3 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.